Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution-Reference-Cited by-同舟云学术

Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution

Published:2014-04-10 Issue:14 Volume:44 Page:E499-E502
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Yoneda Masato¹²,Thomas Emmanuel¹,Sumida Yoshio³,Imajo Kento²,Eguchi Yuichiro⁴,Hyogo Hideyuki⁵,Fujii Hideki⁶,Ono Masafumi⁷,Kawaguchi Takumi⁸,Schiff Eugene R.¹

Affiliation:

1. Schiff Center for Liver Diseases; University of Miami Miller School of Medicine; Miami Florida USA

2. Division of Gastroenterology; Yokohama City University Graduate School of Medicine; Yokohama

3. Department of Gastroenterology and Hepatology; Kyoto Prefectural University of Medicine; Kyoto

4. Liver Center; Saga Medical School; Saga

5. Department of Medicine and Molecular Sciences; Graduate School of Biomedical Sciences; Hiroshima University; Hiroshima

6. Department of Hepatology; Graduate School of Medicine; Osaka City University; Osaka

7. Department of Gastroenterology and Hepatology; Kochi Medical School; Kochi

8. Division of Gastroenterology; Department of Medicine and Digestive Disease Information and Research; Kurume University School of Medicine; Kurume Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12327/fullpdf

Reference12 articles.

1. Nonalcoholic fatty liver disease;Angulo;N Engl J Med,2002

2. Natural history of nonalcoholic steatohepatitis;Liou;J Clin Gastroenterol,2006

3. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis;George;Gastroenterology,1998

4. Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation;Yoneda;Dig Dis Sci,2010

5. Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease;Kowdley;Hepatology,2012

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Ferritin and NAFLD in Patients Undergoing Bariatric Surgery;Obesity Surgery;2022-06-07

2. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer;Journal of Hepatocellular Carcinoma;2022-03

3. Comparison of dapagliflozin and teneligliptin in nonalcoholic fatty liver disease patients without type 2 diabetes mellitus: a prospective randomized study;Journal of Clinical Biochemistry and Nutrition;2021-03-01

4. Serum ferritin level as a noninvasive marker for detection and staging of hepatocellular injury, liver fibrosis, and steatosis in children and adolescents with nonalcoholic fatty liver disease;Alexandria Journal of Pediatrics;2021

5. Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review;Clinical Chemistry and Laboratory Medicine (CCLM);2019-04-24